Aptar Digital Health expands oncology clinical advisory board

Aptar Digital Health announces the expansion of its oncology clinical advisory board.

Comprising leading clinical, oncology and digital experts from across a wide range of cancer specialties, this newly formed clinical advisory board will help to provide critical review and scientific guidance to Aptar Digital Health on the development of its evidence-based medical algorithms.

The new members of the Aptar Digital Health oncology clinical advisory board include

  • Adam DICKER, MD, PhD, Chair and Professor of Radiation Oncology, Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia (PA, US)
  • Marilyn HUANG, MD, Professor of Gynecologic Oncology, Director of Translational Gynecologic Oncology Research, University of Miami, Miami (FL, US)
  • Mario LACOUTURE, MD, Director of the Oncodermatology Program, Memorial Sloan Kettering Cancer Center, New York (NY, US)
  • Aditi U. JOSHI, MD, MSc., Emergency Medicine Physician, Telehealth and Digital Health Expert, US. 

 “We are pleased to strengthen our Clinical Advisory Board and to welcome our new members,” commented Pierre Leurent, President, Aptar Digital Health.

“Their broad medical expertise will allow us to have a deeper knowledge and expand our global vision of the clinical practice for multiple types of cancer.”

Genevieve D’Orsay, MD, Chief Medical Officer at Aptar Digital Health, added: “The clinical advisory board contributes to the design of our clinical algorithms that support patients in the management of treatment-related symptoms."

"The contribution of each member is key to ensuring our solutions address a clinical need. Our advisory board also guides Aptar Digital Health in our clinical strategy decision, including the deployment of clinical studies.”

You may also like